ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NTLA announcements Intellia Therapeutics, Inc. announcements and dividends declared USA

Intellia Therapeutics, Inc. Complete list of announcements declared & dividend announcements by Intellia Therapeutics, Inc. NTLA

Intellia Therapeutics, Inc. NTLA listed on USA and deals in Health Care Biotechnology In Vitro In Vivo Diagnostic Substances

Announcements and dividends declared by Intellia Therapeutics, Inc. NTLA

Intellia Therapeutics Reports Promising Three-Year Follow-Up Data for Lonvo-z in Hereditary Angioedema Patients
Lonvo-z showed a 98% reduction in HAE attacks for 10 patients over three-year follow-up, demonstrating promising safety and efficacy.
Announcement as on 15 June 2025

Why Intellia Therapeutics Stock Plummeted by 20% Today
Thursday was hardly a good day to be a shareholder of Intellia Therapeutics (NASDAQ: NTLA). After the biotech delivered some news from the lab and witnessed one analyst's negative reaction to it, the company's share price closed more than 20% lower.
Announcement as on 24 October 2024

Why Intellia Therapeutics, Inc. (NTLA) Outpaced the Stock Market Today
The most recent trading session ended with Intellia Therapeutics, Inc. (NTLA) standing at .60, reflecting a +1.42% shift from the previouse trading day's closing. This change outpaced the S&P 500's 1.26% gain on the day. On
Announcement as on 03 May 2024

: Intellia Therapeutics stock gains on CRISPR treatment results
Intellia Therapeutics Inc. NTLA shares gained 6.4% premarket on Monday after the clinical stage genome-editing company announced new data from a trial of an investigational CRISPR-based therapy for hereditary angioedema. Patients treated with a single dose
Announcement as on 12 June 2023

Bernstein Initiates Coverage of Intellia Therapeutics (NTLA) with Outperform Recommendation
On March 21, 2023, Bernstein initiated coverage of Intellia Therapeutics with a Outperform recommendation.
Announcement as on 21 March 2023

Announcements by Intellia Therapeutics, Inc. first page | Next page |

NTLA Intellia Therapeutics, Inc. current price & indicator signals

Moving Averages for Intellia Therapeutics, Inc.

  • 5Day Average: 9.21
  • 12Day Average: 9.25
  • 20Day Average: 9.1
  • 50Day Average: 12.72
  • 100Day Average: 13.47
  • 150Day Average: 12.39
  • 200Day Average: 11.28

NTLA Indicators & signals

Indicator MACD (12,26,9)

9.24, 9.83, -0.88
Indicator MACD is in negative zone

Indicator ADX (14)

8.57, 26.39, 22.22
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 49
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NTLA Intellia Therapeutics, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
23 Tue Dec 2025 9.42 9.34 to 9.56 -2.89% 0.85 times
22 Mon Dec 2025 9.70 9.19 to 9.85 4.86% 0.66 times
19 Fri Dec 2025 9.25 8.90 to 9.54 4.17% 0.93 times
18 Thu Dec 2025 8.88 8.74 to 9.16 1.02% 1.11 times
17 Wed Dec 2025 8.79 8.78 to 9.55 -3.62% 1.08 times
16 Tue Dec 2025 9.12 8.91 to 9.26 -0.22% 0.83 times
15 Mon Dec 2025 9.14 8.90 to 9.23 1.33% 1.31 times
12 Fri Dec 2025 9.02 9.02 to 9.68 -5.55% 1.13 times
11 Thu Dec 2025 9.55 9.25 to 9.67 1.92% 1.01 times
10 Wed Dec 2025 9.37 9.15 to 9.70 0.75% 0.91 times
09 Tue Dec 2025 9.30 9.22 to 9.60 -1.48% 1.04 times
08 Mon Dec 2025 9.44 9.35 to 9.95 -1.77% 1.14 times

Videos related to: NTLA announcements Intellia Therapeutics, Inc. announcements and dividends declared USA

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

NTLA announcements Intellia Therapeutics, Inc. announcements and dividends declared USA

 

Back to top